Thoracic
Surgeon

     

Specializing in Precision Thoracic Surgery

   
EVERYTHING
START WITH
BREATH
    Thoracic Surgery
ADVANTAGE

Thoracic Surgery Excellence

  • Reliable Quality of Thoracic Surgery

    Professional lung cancer specialists and a high-quality medical team ensure the quality of thoracic surgery for patients.

  • Private ICU Rooms for Post-Thoracic Surgery Care
  • Personalized Thoracic Surgery Plans

    Thorough preoperative evaluation by an experienced thoracic surgeon to select the optimal thoracic surgery approach and minimize functional loss.

  • Advanced Thoracic Surgery Skills

    Proficient in advanced surgical techniques such as single-port thoracoscopic surgery and single-port robotic surgery.

  • Years of Clinical Research and Surgical Experience

    Experienced in various thoracic conditions, such as lung cancer, mediastinal tumors, intravenous port, and lung ground-glass opacities.

  • Considering Patient Conditions to Minimize Surgical Damage

    Comprehensive preoperative evaluation, taking into account the patient's physical condition, to reduce surgical risks and damage to a minimum.

  • Postoperative Care by Experienced Thoracic Surgeons

    Thoracic surgeons track imaging to detect recurrence early and optimize thoracic surgery outcomes.

Thoracic Surgeon

Thoracic Surgeon

DR. CHING-YANG WU

Lung surgery is complex and requires precise technique. Its success largely depends on the experience and skills of the thoracic surgeon.

  • Single-port thoracoscopic surgery for lung cancer/lung tumors
  • Single-port robotic surgery for lung cancer/lung tumors
  • Single-port thoracoscopic surgery for mediastinal tumors
  • Intravenous port implantation (Chemoport)
  • Follow-up and treatment of lung ground-glass opacities

About DR. CHING-YANG WU

20

  • Attending Thoracic Surgeon at Linkou Chang Gung Memorial Hospital
  • Associate Professor of Surgery at Chang Gung University
  • Associate Professor of Surgery at Chang Gung Memorial Hospital
  • Instructor of the Taiwan Society of Thoracic and Cardiovascular Surgery
  • Instructor of the Taiwan Society of Thoracic Surgery

Thoracic SurgeonGet Immediate Help

ReachOut

Thoracic Booking

Chang GungTaoyuan

Chang GungLinkou

  • Address:No. 5, Fuxing St., Guishan Dist., Taoyuan City
  • Call to Book:03-3281200
  • Clinic Hours:Fri. 1:00 PM – 5:00 PM
  • Book Now:Linkou Chang Gung Thoracic Surgery

Types of
Thoracic
Surgery

SERVICE
Lung Cancer Surgery

Lung Cancer Surgery3D imaging

3D imaging aids tumor resection planning, with CT localization and...

Mediastinal Tumor Surgery
Mediastinum

MediastinumHolistic Evaluation

Considers tumor size, location, and involvement of vital organs, followed...

Mediastinal Tumor Surgery
Port Placement Surgery

Port Placement SurgeryPort A

Considers the patient's treatment needs and vascular involvement of...

Port Placement Surgery
Lung GGO

Lung GGOImaging Evaluation

Evaluate size, density changes, and initial imaging...

Lung GGO
 

Timing for Thoracic Care

Thoracic symptoms are often non-specific, making diagnosis challenging.

Here’s a quick guide to common signs.

Thoracic Surgery Process

  • Disease Evaluation
    1

    Disease Evaluation

    Assess disease severity with imaging tests.

  • Preoperative Assessment
    2

    Preoperative Assessment

    Confirm tumor location and plan surgery.

  • Thoracic Surgery
    3

    Thoracic Surgery

    Perform surgery with minimal tissue damage.

  • Post-Surgical Care
    4

    Post-Surgical Care

    Monitor recovery and pathology results.

  • Follow-up Care
    5

    Follow-up Care

    Plan and compare follow-up care based on imaging.

心血管專科常見問題

Thoracic Surgery Q&A

Thoracic surgery covers conditions involving the lungs, trachea, esophagus, pleural cavity, mediastinum, and chest wall.

What should you know about it?

What is the definition of thoracic surgery?

Thoracic surgery involves operations on chest organs like the lungs, trachea, and esophagus.
It is used to treat lung cancer, mediastinal tumors, and other serious chest conditions.

What are the surgical options for lung cancer?

Most are performed via single-port thoracoscopy, with robotic assistance for precision.
Surgeons can also perform these procedures using robotic arms through a single incision.

How is lung cancer treated?

Treatment depends on tumor staging.
For tumors limited to one lung lobe or nearby lymph nodes, surgery with preoperative therapy is recommended.
If the tumor has spread beyond the same side of the chest, systemic treatments like targeted therapy, immunotherapy, and chemotherapy are used.

How long is the recovery after thoracic surgery?

Recovery after thoracic surgery varies by procedure and health condition.
Minimally invasive surgeries like single-port thoracoscopy allow discharge in 3–5 days and full recovery in 2–4 weeks.
Open surgery may take 6–8 weeks.
Good postoperative care helps ensure smooth recovery.

Lung tumor surgery risks? Any other options?

Surgery is the best option for malignant tumors with good heart and lung function.
If the tumor is benign or biopsy results are unclear, further biopsy or regular imaging follow-up for 2-3 years may be considered.

Is a ground-glass opacity always malignant?

Ground-glass opacity (GGO) is a neutral term, indicating tissue density higher than surrounding lung tissue.
It does not necessarily mean malignancy. "Ground-glass" refers to the foggy appearance on CT, caused by varying radiation penetration in GGO and normal lung tissue.

What are the symptoms of mediastinal tumors?

Mediastinal tumors may cause symptoms such as cough, chest fullness, shortness of breath, substernal pain, and weight loss.
However, some patients may remain asymptomatic, and tumors are discovered incidentally during imaging for other reasons.

What is an intravenous port?

An intravenous port provides easy vascular access for repeated treatments, reducing puncture frequency and improving comfort, especially for chemotherapy patients.
It is placed in the superior vena cava to minimize clot risk.

What are intravenous ports and their limits?

Intravenous ports included power-injectable ports( high injection pressure, up to 300 psi)and conventional one ( normal injection pressure, 180-200 psi).Power injectable port( high injection pressure ) support tumor treatment and contrast injection, while standard ones are for treatment only. Use non-traumatic needles and flush well after blood draws, transfusions, or IV nutrition to prevent infection or blockage.

Is intravenous port placement surgery safe?

The procedure is a safe outpatient surgery with minimal complications.
Dr. Wu's protocol reduces pneumothorax risks and the need for neck vein puncture. Mobile X-ray and ultrasound guidance ensure accurate placement and reduce infection and displacement risks.

Clinical vs. Pathological Staging

Clinical staging uses imaging, but may underestimate small or low-metabolism tumors.
Pathological staging is based on tissue examination, offering a more accurate assessment.
Around 10% of patients may receive a different treatment plan due to more severe pathological findings.

More Thoracic Surgery Articles
NEW POST

PressCoverage

Health LTNHealth LTN

Advancing Large-Cell Lung Cancer Treatment: NCYU & Chang Gung Memorial Hospital, Linkou Collaborate

Associate Professor of NCYU and Dr. Wu’s team collaborate on large-cell lung cancer research, yielding significant findings...

2021/04/08
Advancing Large-Cell Lung Cancer Treatment: NCYU & Chang Gung Memorial Hospital, Linkou Collaborate
Advancing Large-Cell Lung Cancer Treatment: NCYU & Chang Gung Memorial Hospital, Linkou Collaborate
Mepa.InnovaradMepa.Innovarad

Dr. Wu Receives AATS Graham Award at ASCVTS 2016

Dr. Wu excelled in the AATS Graham Award evaluation, delivering his research within the 12-minute limit (10-minute presentation + 2-minute Q&A)...

2016/04/14
Dr. Wu Receives AATS Graham Award at ASCVTS 2016
Dr. Wu Receives AATS Graham Award at ASCVTS 2016
Mepa.InnovaradMepa.Innovarad

Dr. Wu’s Team Publishes Study on Three CT-Guided Techniques for Lung Lesion Localization in the European Journal of Radiology!

From September 2019 to August 2021, the team analyzed 418 patients with lung lesions, comparing three CT-guided...

2024/04/08
Dr. Wu’s Team Publishes Study on Three CT-Guided Techniques for Lung Lesion Localization in the European Journal of Radiology!
Dr. Wu’s Team Publishes Study on Three CT-Guided Techniques for Lung Lesion Localization in the European Journal of Radiology!
Mepa.InnovaradMepa.Innovarad

Dr. Wu’s Team Publishes Study on 3D Simulation Training for Oncology Nurses in Seminars in Oncology Nursing!

Since implantable venous catheters are not visible to the naked eye and can only be identified by touch, improper handling may occur...

2023/08/31
Dr. Wu’s Team Publishes Study on 3D Simulation Training for Oncology Nurses in Seminars in Oncology Nursing!
Dr. Wu’s Team Publishes Study on 3D Simulation Training for Oncology Nurses in Seminars in Oncology Nursing!
Clip.InnovaradClip.Innovarad

Dr. Wu’s Research on Implantable Venous Ports Published in Medicine!

Based on literature and clinical experience, Dr. Wu formulated a standard algorithm to evaluate the best entry vessel for...

2021/10/27
Dr. Wu’s Research on Implantable Venous Ports Published in Medicine!
Dr. Wu’s Research on Implantable Venous Ports Published in Medicine!
Clip.InnovaradClip.Innovarad

Dr. Wu’s Lung Cancer Research Published in Medicine!

Many patients still experience recurrent non-small cell lung cancer (NSCLC). To investigate, Dr. Wu and his team reviewed data from 356 stage I lung cancer patients (2005–2011), finding...

2021/08/27
Dr. Wu’s Lung Cancer Research Published in Medicine!
Dr. Wu’s Lung Cancer Research Published in Medicine!
Clip.InnovaradClip.Innovarad

Dr. Wu’s Team Publishes Prognostic Study on Lung Adenocarcinomas ≤2cm in the Journal of the Formosan Medical Association!

The study aims to identify unique prognostic factors with clinical significance. Retrospective analysis of cases from...

2020/09/14
Dr. Wu’s Team Publishes Prognostic Study on Lung Adenocarcinomas ≤2cm in the Journal of the Formosan Medical Association!
Dr. Wu’s Team Publishes Prognostic Study on Lung Adenocarcinomas ≤2cm in the Journal of the Formosan Medical Association!
Clip.InnovaradClip.Innovarad

Dr. Wu’s Team Publishes Study on Postoperative Circulating Tumor Cells as a Predictor of Lung Cancer Recurrence in Diagnostics!

With extensive experience in lung cancer surgery, Dr. Wu’s team investigated whether changes in circulating tumor cells (CTC)...

2020/03/23
Dr. Wu’s Team Publishes Study on Postoperative Circulating Tumor Cells as a Predictor of Lung Cancer Recurrence in Diagnostics!
Dr. Wu’s Team Publishes Study on Postoperative Circulating Tumor Cells as a Predictor of Lung Cancer Recurrence in Diagnostics!
Clip.InnovaradClip.Innovarad

Dr. Wu’s Study on Central Venous Catheter Tip Placement Published in Medicine!

After analyzing 346 cases, Dr. Wu found that 221 cases (63.9%) were in the non-migration group, 67 cases (19.4%)...

2019/11/04
Dr. Wu’s Study on Central Venous Catheter Tip Placement Published in Medicine!
Dr. Wu’s Study on Central Venous Catheter Tip Placement Published in Medicine!
Clip.InnovaradClip.Innovarad

Dr. Wu’s Research on a New Implantable Injection Port Published in Journal of Biomedical Materials Research Part B: Applied Biomaterials!

With in-depth studies and extensive clinical experience in implantable intravenous ports, Dr. Wu has explored complications...

2017/05/17
Dr. Wu’s Research on a New Implantable Injection Port Published in Journal of Biomedical Materials Research Part B: Applied Biomaterials!
Dr. Wu’s Research on a New Implantable Injection Port Published in Journal of Biomedical Materials Research Part B: Applied Biomaterials!
Dr. Wu’s Expertise
  • 2011 Taiwan Thoracic & Cardiovascular Surgery New Scholar Award
  • 2012 Taiwan Thoracic & Cardiovascular Surgery President’s Award
  • 2014 Taiwan Vascular Surgery Smart Award
  • 2015 Taiwan Vascular Surgery Smart Award
  • 2016 AATS Graham Award
  • 2020 Taiwan Thoracic & Critical Care Medicine Best Paper
  • 2021 Taiwan Thoracic & Cardiovascular Surgery President’s Award
  • 2023 Global Injection Port Consensus Conference
Health Education

InfoVideo

YoutubeYoutube

What Is a Port-A?

Port-A types can be classified by catheter material, high-pressure compatibility, and injection port material. Catheters are mainly made of silicone…

           
2024/03/15
What Is a Port-A?
What Is a Port-A?
YoutubeYoutube

Why Get a Port-A?

A brief overview of the reasons for Port-A placement…

           
2024/03/15
Why Get a Port-A?
Why Get a Port-A?
YoutubeYoutube

What Is a High-Pressure Port-A?

An overview of high-pressure Port-A and its clinical benefits…

           
2024/03/15
What Is a High-Pressure Port-A?
What Is a High-Pressure Port-A?
YoutubeYoutube

How Do Healthcare Providers Use a High-Pressure Port-A?

Identification and injection procedure for high-pressure Port-A…

           
2024/03/15
How Do Healthcare Providers Use a High-Pressure Port-A?
How Do Healthcare Providers Use a High-Pressure Port-A?
YoutubeYoutube

Post-Op Care for Port-A

Daily activities remain unrestricted, but certain movements depend on port placement…

           
2024/03/15
Post-Op Care for Port-A
Post-Op Care for Port-A
YoutubeYoutube

Port-A Placement: What to Expect

An implantable venous port, commonly known as a Port-A, serves as a reliable IV access for clinical treatments. It functions like an invisible socket placed under the skin, allowing injection needles—like…

2024/03/15
Port-A Placement: What to Expect
Port-A Placement: What to Expect

Thoracic SurgeonGet Immediate Help

ReachOut
NEW POST

MedicalInsights

2025 年 4 月 21 日

Lung Cancer Metastasis: Survival, Spread Rate, and Treatment Tips

The patterns of lung cancer metastasis differ significantly between patients with early-stage lung cancer who are eligible for curative resection and those diagnosed at stages IIIB or IV. As a result, treatment approaches and subsequent prognostic outcomes also vary...
2025 年 3 月 26 日

Lung Cancer Treatment Guide: Surgery and Systemic Therapy

With advancements in tumor treatment, lung cancer treatment guidelines have continually improved, leading to an increasing number of patients discovering pulmonary lesions during follow-up. Depending on the clinical scenario, the management approach and recommendations for these lesions may vary.

中文